SHANGHAI and CAMBRIDGE, Mass, Nov. 14, 2026 /PRNewswire/ -- Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688), an innovation-driven, global biopharma company, today announced that five of its commercial medicines in China have been included in the country's 2026 National Reimbursement Drug List (NRDL). The update includes two first-time listings,...
SHANGHAI, Sept. 16, 2025 /PRNewswire/ -- With the 8th China International Import Expo (CIIE) drawing nearer, preparations are accelerating across all fronts. As the world's...
Editor's note: China Daily is publishing a series illustrating the efforts being made to achieve the country's carbon peak and carbon neutrality goals. ...
NEW YORK, Sept. 16, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today the appointment of John Gellatly as Senior Advisor. Based in...
XUZHOU, China, Sept. 16, 2025 /PRNewswire/ -- On September 9, Mr. Chen Yiwan, Equipment Supervisor at China Tower Corporation Limited Xuzhou Xinyi Branch, visited...
SHENZHEN, China, Sept. 16, 2025 /PRNewswire/ -- Ambilight has been named to the MIT Technology Review TR50 list of "50 Smartest Companies," a recognition of...
